Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIFE | AMGN | BMY | GILD | VRTX |
| Company | Atyr Pharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.6000 | 265.64 | 47.93 | 67.01 | 394.19 |
| High | 1.6400 | 265.92 | 48.20 | 67.02 | 394.96 |
| Low | 1.5800 | 263.25 | 47.62 | 65.90 | 391.01 |
| Last | 1.6350 | 263.87 | 47.95 | 66.02 | 393.40 |
| Change | +0.0450 | -0.20 | +0.11 | -0.91 | +0.30 |
| % Change | +2.83% | -0.08% | +0.23% | -1.36% | +0.08% |
| Volume | 164,129 | 536,797 | 3,994,327 | 2,540,513 | 316,984 |
| 20-Day Average Volume | 440,898 | 2,123,491 | 11,062,054 | 6,016,090 | 877,109 |
| Previous Close | 1.5900 | 264.07 | 47.84 | 66.93 | 393.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8220 | 273.06 | 50.98 | 70.21 | 406.59 |
| 20-Day Raw Stochastic | 10.78% | 5.65% | 7.23% | 2.33% | 8.44% |
| 20-Day Relative Strength | 42.04% | 38.41% | 36.44% | 27.77% | 37.00% |
| Weighted Alpha | -17.19 | +5.32 | -30.51 | -25.37 | +15.66 |
| Today's Opinion | 40% Buy | 56% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 8% Buy | 56% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.10% since 04/11/24 | -1.97% since 04/11/24 | -2.03% since 04/11/24 | -3.72% since 04/11/24 | -1.66% since 04/11/24 |
| Low | 1.5800 on 04/17/24 | 263.25 on 04/18/24 | 47.63 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.7800 on 04/12/24 | 270.93 on 04/15/24 | 49.10 on 04/15/24 | 68.62 on 04/12/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -16.37% since 03/18/24 | -2.30% since 03/18/24 | -6.72% since 03/18/24 | -9.78% since 03/18/24 | -4.33% since 03/18/24 |
| Low | 1.5800 on 04/17/24 | 263.25 on 04/18/24 | 47.63 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 2.1500 on 03/20/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +15.14% since 01/18/24 | -13.07% since 01/18/24 | -3.92% since 01/18/24 | -23.50% since 01/18/24 | -9.10% since 01/18/24 |
| Low | 1.4222 on 01/19/24 | 263.25 on 04/18/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 2.1500 on 03/20/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +22.93% since 10/18/23 | -6.66% since 10/18/23 | -15.35% since 10/18/23 | -17.04% since 10/18/23 | +7.08% since 10/18/23 |
| Low | 1.0801 on 11/13/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 2.1500 on 03/20/24 | 329.72 on 02/05/24 | 57.09 on 10/20/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 108,026 | 141,520,144 | 96,960,152 | 83,333,008 | 101,600,240 |
| Shares Outstanding, K | 67,941 | 535,919 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 350,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -50,390,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 350,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -11,340,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.25 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 03/14/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 6.43 | 10.02 | 29.33 |